The Compounding Landscape An estimated 1.5 million Americans have used compounded versions of semaglutide and tirzepatide, primarily through telehealth platforms offering lower-cost alternatives during drug shortages
Semaglutide is a GLP-1 analogue approved as a once-weekly, subcutaneous treatment for T2D [5, 6]
Healthcare professionals should maintain awareness that whilst there is no official link, individual patient experiences warrant investigation, and any new pelvic symptoms should be evaluated on their clinical merits rather than automatically attributed to medication
Dont let COVID-19 hold you back any longer
Wang W, Yan X, Cheng Z, Zhang Q, Wang R, Deng Y, et al
Though studies are inconclusive, researchers are developing an understanding of how GLP-1s affect complexion